This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Möller, L. V. M.
Right arrow Articles by Dankert, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Möller, L. V. M.
Right arrow Articles by Dankert, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1998, p. 319-324, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Antimicrobial Susceptibility of Haemophilus influenzae in the Respiratory Tracts of Patients with Cystic Fibrosis

Lieke V. M. Möller,1,2 Annette G. Regelink,1 Henny Grasselier,1 Loek van Alphen,1,* and Jacob Dankert1

Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam,1 and Department of Medical Microbiology, University Hospital Groningen and Laboratory for Public Health, Groningen,2 The Netherlands

Received 3 March 1997/Returned for modification 19 July 1997/Accepted 26 November 1997

We analyzed the antimicrobial susceptibilities of Haemophilus influenzae isolates from 157 sputum specimens prospectively collected from 39 cystic fibrosis (CF) patients during a 2-year study. These isolates were characterized by random amplified polymorphic DNA analysis and major outer membrane protein (MOMP) analysis to identify H. influenzae strains and MOMP variants and to assess their persistence in the respiratory tract. Among the 247 H. influenzae isolates, 16 (6.5%) produced beta -lactamase. The 231 beta -lactamase-negative isolates represented 85 H. influenzae strains, 61 MOMP variants derived from 27 of these strains, and 85 persistent isolates identical to strains or MOMP variants. All beta -lactamase-negative isolates were tested for susceptibility to ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefotaxime, cefaclor, imipenem, tetracycline, and trimethoprim-sulfamethoxazole by disk diffusion testing. Eleven (13%) H. influenzae strains, 18 (30%) MOMP variants, and 30 (35%) persistent isolates were resistant to one or more of the antibiotics tested. Antimicrobial susceptibility was decreased among MOMP variants and persistent isolates compared to nonpersistent H. influenzae strains, and changes in susceptibility occurred irrespective of MOMP variation. We conclude that the decreased antimicrobial susceptibility of H. influenzae during persistence contributes to the poor eradication of H. influenzae from the respiratory tracts of CF patients.


* Corresponding author. Mailing address: Laboratory for Vaccine Development and Mechanisms of Immunity (L.V.M.), National Institute for Public Health and Environment (RIVM), P.O. Box 1, NL-3720 BA Bilthoven, The Netherlands. Phone: 31-30-2742701. Fax: 31-30-2744429. E-mail: Loek.van.Alphen{at}RIVM.NL.


Antimicrobial Agents and Chemotherapy, February 1998, p. 319-324, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Roman, F., Canton, R., Perez-Vazquez, M., Baquero, F., Campos, J. (2004). Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains. J. Clin. Microbiol. 42: 1450-1459 [Abstract] [Full Text]  
  • Dabernat, H., Delmas, C., Seguy, M., Pelissier, R., Faucon, G., Bennamani, S., Pasquier, C. (2002). Diversity of {beta}-Lactam Resistance-Conferring Amino Acid Substitutions in Penicillin-Binding Protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46: 2208-2218 [Abstract] [Full Text]  
  • Heath, P T, Breathnach, A S (2002). Treatment of infections due to resistant organisms: Childhood respiratory infections. Br Med Bull 61: 231-245 [Abstract] [Full Text]